Back to results
US 2017/0253615 A1Published application
Spirocyclic derivatives
AssigneeChronos Therapeutics Limited
InventorsSusanna CREMONESI, Tim LUKER, Teresa SEMERARO, Fabrizio MICHELI
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease, disorder or condition ameliorated by inhibition of a dopamine transporter); and methods of treating patients with such compounds; wherein R1, R2, R3, R4, R5, R6, R9, R10, Q, X, Y, Z, A, L, B, m, n and p are as defined herein.
Claims17
A compound according to formula I,
- wherein:
- Q is selected from CR7R8, C═O, C═N—OH, C═N—O-alkyl, S(O)q, O, NH, N-cycloalkyl and N-alkyl;
- X is selected from C═O, CR11R12, NH and N-alkyl;
- Y is selected from CR11R12, NH and O;
- wherein:
- X is C═O or CR11R12 when Y is O or NH;
- X is C═O or CR11R12 when p is 0 and Q is S(O)q, O, NH, N-cycloalkyl or N-alkyl;
- Y is CR11R12 when X is NH, or N-alkyl;
- Q is selected from CR7R8, C═O, C═N—OH and C═N—O-alkyl when n is 0;
- Q is CR7R8 when p is 0 and X is NH or N-alkyl;
- Q is CR7R8, O, NH, N-cycloalkyl or N-alkyl when p is 0 and X is C═O;
- Q is NH, N-cycloalkyl, or N-alkyl and X is CR11R12 when Y is O, and
- at least one of Q, X and Y is NH, N-cycloalkyl or N-alkyl;
- Z is selected from CR11R12, O and S;
- wherein Z is CR11R12 when Q is O, S(O)q, NH, N-cycloalkyl or N-alkyl, or when m is 0, or when n is 0;
- A is selected from phenyl and heteroaryl;
- B is selected from phenyl and heteroaryl;
- L is a linker selected from alkylene and O;
- R1 is selected from H, OH, alkyl, F, Cl and alkoxy;
- R2 is selected from H, OH, alkyl, F, Cl and alkoxy;
- or R1 and R2 may together form ═O;
- R3 and R4 are independently selected from H, OH, alkoxy and alkyl;
- or R3 and R4 may both be O, wherein said O atoms are linked by an alkylene group to form a straight chain or branched alkylenedioxy group;
- or R3 and R4 may together form ═O;
- R5 and R6 are independently selected from H and alkyl;
- R7 is selected from H, F, Cl, OH, alkoxy, and alkyl;
- R8 is selected from H, F, Cl, OH, alkoxy and alkyl;
- or R7 and R8 may both be O, wherein said O atoms are linked by an alkylene group to form a straight chain or branched alkylenedioxy group;
- R9 is H or alkyl;
- R10 is H or alkyl;
- R11 and R12 are independently selected from H and alkyl;
- R13 and R14 are independently selected from H and alkyl;
- q is 0, 1 or 2;
- n is 0, 1 or 2, wherein n is 0 or 1 when m is 2 and n is 1 or 2 when m is 0;
- m is 0, 1 or 2, wherein m is 0 or 1 when n is 2 and m is 1 or 2 when n is 0;
- p is 0, 1 or 2, wherein p is 1 or 2 when m is 1 and n is 1 or when n is 2 and m is 0;
- alkyl is a linear saturated hydrocarbon having up to 6 carbon atoms (C1-C6) or a branched saturated hydrocarbon of between 3 and 6 carbon atoms (C3-C6);
- alkyl may optionally be substituted with 1, 2, 3, 4 or 5 substituents independently selected from S-alkyl, S(O)alkyl, S(O)2alkyl, cycloalkyl, heterocyclyl, alkoxy, OH, —CN, CF3, COOR13, CONR13R14, F, Cl, NR13COR14 and NR13R14;
- alkylene is a bivalent C1-3 straight-chained alkyl radical or a bivalent C3-4 branched alkyl radical, wherein alkylene may optionally be substituted with 1 or 2 substituents selected from S-alkyl, S(O)alkyl, S(O)2alkyl, heterocyclyl, alkoxy, OH, —CN, CF3, COOR13, CONR13R14, F, Cl, NR13COR14 and NR13R14;
- alkoxy is a linear O-linked hydrocarbon of between 1 and 6 carbon atoms (C1-C6) or a branched O-linked hydrocarbon of between 3 and 6 carbon atoms (C3-C6);
- alkoxy may optionally be substituted with 1, 2, 3, 4 or 5 substituents independently selected from S-alkyl, S(O)alkyl, S(O)2alkyl, alkyl, OH, —CN, CF3, COOR13, CONR13R14, F, Cl, NR13COR14 and NR13R14;
- cycloalkyl is a monocyclic saturated hydrocarbon of between 3 and 7 carbon atoms;
- cycloalkyl may optionally be substituted with 1, 2, 3, 4 or 5 substituents independently selected from S-alkyl, S(O)alkyl, S(O)2alkyl, alkyl, alkoxy, OH, —CN, CF3, COOR13, CONR13R14, F, Cl, NR13COR14 and NR13R14;
- phenyl may be optionally substituted with 1, 2 or 3 substituents independently selected from alkyl, cycloalkyl, heterocyclyl, alkoxy, S-alkyl, S(O)alkyl, S(O)2alkyl, OH, F, Cl, —CN, OCF3, CF3, NR13COR14 and NR13R14;
- heteroaryl is a 5 or 6 membered aromatic ring, containing, where possible, 1, 2 or 3 ring members independently selected from N, NR13, S and O;
- heteroaryl may be optionally substituted with 1, 2 or 3 substituents independently selected from alkyl, cycloalkyl, heterocyclyl, alkoxy, S-alkyl, S(O)alkyl, S(O)2alkyl, OH, F, Cl, —CN, OCF3, CF3, NR13COR14 and NR13R14;
- heterocyclyl is a monocyclic ring which is saturated or partially unsaturated, containing, where possible, 1 or 2 ring members independently selected from N, S, O and NR13 and 2 to 5 carbon atoms;
- heterocyclyl may optionally be substituted with 1, 2 or 3 substituents independently selected from alkyl, cycloalkyl, alkoxy, S-alkyl, S(O)alkyl, S(O)2alkyl, oxo, OH, F, Cl, —CN, OCF3, CF3, NR13COR14 and NR13R14;
- and tautomers, stereoisomers (including enantiomers, diastereoisomers and racemic and scalemic mixtures thereof), pharmaceutically acceptable salts and solvates thereof;
- wherein:
- R1 is not OH or alkoxy when Q is NH, N-alkyl, N-cycloalkyl or when X is NH;
- and
- R2 is not OH or alkoxy when Q is NH, N-alkyl, N-cycloalkyl or when X is NH;
- and
- R3 is not OH or alkoxy when Y is O or NH;
- and
- R4 is not OH or alkoxy when Y is O or NH;
- and wherein the compound of formula I is not:
55 more elements
(canceled)
Dependencies are inferred from the claim text.